test

Jeffrey A Orell MD

Assistant Clinical Professor of Medicine

Clinical Interests

clotting disorders; red blood cell disorders; breast cancer; lymphoma; colorectal cancer, and lung cancer.


Board Certifications

1986
Hematology (Internal Medicine), Board Certified
1982
Internal Medicine, Board Certified
1985
Medical Oncology, Board Certified

Patient Care Locations

jeffrey_orellfaculty-clinicsfalsetruetrue6truefalsefalse

Clinical Trials

ConditionsStudy Title
Colorectal Cancer and ColonC80702: A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer
PancreasS1310: Randomized Phase II Trial of Single Agent MEK Inhibitor Trametinib (GSK1120212) Vs 5-Fluorouracil or Capecitabine in Refractory Advanced Biliary Cancer
Breast - Female and Breast - MaleA Phase II Study with Orteronel as Monotherapy in Patients with Metastatic Breast Cancer (MBC) that Expresses the Androgen Receptor (AR)
Leukemia, otherA Randomized Phase III Study of Bendamustine Plus Rituximab Versus Ibrutinib Plus Rituximab Versus Ibrutinib Alone in Untreated Older Patients (=65 Years of Age) with Chronic Lymphocytic Leukemia (CLL)
Breast - FemaleA neoadjuvant phase II trial of aromatase inhibitors in combination with everolimus in postmenopausal women with hormone receptor positive/HER2 negative breast cancers with low and intermediate risk (less than or equal to 25) Oncoptype Dx Recurrence Scores

More Clinical Trials...

Edit Profile